Company intelligence / Profile preview

Raffles PharmaTech

Huizhou, Guangdong, China

Ownership: Private
Employees: ~400
Development stage: Commercial

Overview

Raffles PharmaTech is an established China-based CDMO specializing in custom synthesis, process development, and cGMP manufacturing of small molecule advanced intermediates, KSMs, RSMs, and APIs for global pharmaceutical innovators. The company operates two sites in Guangdong province with significant capacity for both clinical and commercial supply.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

celecoxib

Commercial

Indications: Acute pain, Osteoarthritis, Rheumatoid arthritis

Beyond the preview

Go deeper on Raffles PharmaTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Raffles PharmaTech.

Explore the full profile